Skip to main content

Table 1 Demographic and clinical characteristics of the CAPTURE study sample overall and stratified by CVD status

From: CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

Characteristic Overall
N = 9823
By CVD status
CVD
n = 3582
Non-CVD
n = 6241
n Data n Data n Data
Female, n (%) 9823 4465 (45.5) 3582 1388 (38.7) 6241 3077 (49.3)
Age, years, median [IQR] 9823 64.0 [56.0–71.0] 3582 68.0 [61.0–75.0] 6241 62.0 [54.0–69.0]
Race, n (%) 9822   3581   6241  
 White   6487 (66.0)   2558 (71.4)   3929 (63.0)
 Asian   2133 (21.7)   718 (20.1)   1415 (22.7)
 Black or African American   158 (1.6)   66 (1.8)   92 (1.5)
 Other   1044 (10.6)   239 (6.7)   805 (12.9)
Diabetes duration, years, median [IQR] 9811 10.7 [5.6–17.9] 3577 13.0 [7.2–20.0] 6234 9.8 [4.8–15.9]
HbA1c, %, median [IQR] 9104 7.30 [6.60–8.40] 3289 7.40 [6.60–8.50] 5815 7.30 [6.50–8.30]
HbA1c, mmol/mol, median [IQR] 9104 56 [49–68] 3289 57 [49–69] 5815 56 [48–67]
FPG, mmol/L, median [IQR] 8204 7.60 [6.30–9.38] 2924 7.60 [6.21–9.43] 5280 7.60 [6.33–9.32]
Body weight, kg, median [IQR] 9742 79.3 [68.7–92.0] 3550 79.8 [69.0–92.0] 6192 79.0 [68.3–92.0]
BMI, kg/m2, median [IQR] 9611 29.0 [25.8–33.1] 3514 28.9 [25.7–33.1] 6097 29.1 [25.8–33.1]
Systolic blood pressure, mmHg, median [IQR] 9618 130.0 [120.0–140.0] 3531 130.0 [120.0–142.0] 6087 130.0 [120.0–140.0]
Diastolic blood pressure, mmHg, median [IQR] 9616 78.0 [70.0–82.0] 3529 76.0 [70.0–81.0] 6087 80.0 [70.0–83.0]
Total cholesterol, mmol/L, median [IQR] 8272 4.34 [3.68–5.14] 3001 4.05 [3.39–4.82] 5271 4.51 [3.83–5.26]
LDL cholesterol, mmol/L, median [IQR] 8090 2.39 [1.81–3.08] 2924 2.12 [1.62–2.77] 5166 2.54 [1.98–3.19]
HDL cholesterol, mmol/L, median [IQR] 7965 1.15 [0.98–1.40] 2907 1.11 [0.93–1.32] 5058 1.18 [0.99–1.42]
Triglyceride, mmol/L, median [IQR] 8466 1.60 [1.13–2.27] 3082 1.61 [1.14–2.30] 5384 1.59 [1.13–2.25]
eGFR, mL/min/1.73 m2, n (%) 7923   2888   5035  
 > 89   2746 (34.7)   707 (24.5)   2039 (40.5)
 > 59–89   3512 (44.3)   1293 (44.8)   2219 (44.1)
 > 29–59   1450 (18.3)   757 (26.2)   693 (13.8)
 ≤ 29   215 (2.7)   131 (4.5)   84 (1.7)
Albuminuriaa, n (%) 6482   2433   4049  
 Normal–mildly increased   4338 (66.9)   1396 (57.4)   2942 (72.7)
 Microalbuminuria   1607 (24.8)   774 (31.8)   833 (20.6)
 Macroalbuminuria   537 (8.3)   263 (10.8)   274 (6.8)
Medical history of hypertension, yes, n (%) 9643 6756 (70.1) 3522 2918 (82.9) 6121 3838 (62.7)
Familial hypercholesterolemia, yes, n (%) 6634 676 (10.2) 2342 246 (10.5) 4292 430 (10.0)
Retinopathy, n (%) 9818   3578   6240  
 Yes   1455 (14.8)   725 (20.3)   730 (11.7)
 Yes (referred by participant)   399 (4.1)   144 (4.0)   255 (4.1)
 No   7964 (81.1)   2709 (75.7)   5255 (84.2)
Nephropathy, n (%) 9818   3579   6239  
 Yes   1771 (18.0)   917 (25.6)   854 (13.7)
 Yes (referred by participant)   337 (3.4)   128 (3.6)   209 (3.3)
 No   7710 (78.5)   2534 (70.8)   5176 (83.0)
Neuropathy, n (%) 9817   3577   6240  
 Yes   1774 (18.1)   867 (24.2)   907 (14.5)
 Yes (referred by participant)   459 (4.7)   168 (4.7)   291 (4.7)
 No   7584 (77.3)   2542 (71.1)   5042 (80.8)
Smoking status, n (%) 9725   3547   6178  
 Current   1322 (13.6)   465 (13.1)   857 (13.9)
 Previous   2613 (26.9)   1268 (35.7)   1345 (21.8)
 Never   5790 (59.5)   1814 (51.1)   3976 (64.4)
Duration of smokingb, years, median [IQR] 3733 28.0 [15.0–39.0] 1646 30.0 [20.0–40.0] 2087 25.0 [15.0–35.0]
Physical activityc, days per week, n (%) 7492   2763   4729  
 0–1   3599 (48.0)   1515 (54.8)   2084 (44.1)
 2–3   1613 (21.5)   497 (18.0)   1116 (23.6)
 4–5   883 (11.8)   264 (9.6)   619 (13.1)
 6–7   1397 (18.6)   487 (17.6)   910 (19.2)
  1. To convert the values for glucose to mg/dL, divide by 0.0555. To convert the values for cholesterol to mg/dL, divide by 0.0259. To convert the values for triglycerides to mg/dL, divide by 0.0113. Data that were missing from the medical record but verbally confirmed by a participant were coded as ‘referred by participant’. Data were not weighted
  2. aDefined as: normal–mildly increased, urinary excretion < 30 mg/24 h or UACR < 30 mg/g; microalbuminuria, urinary excretion 30–299 mg/24 h or UACR 30–299 mg/g; macroalbuminuria, urinary excretion ≥ 300 mg/24 h or UACR ≥ 300 mg/g
  3. bOnly applies to participants categorized as current or previous smokers
  4. cDays with ≥ 30 min of moderate activity
  5. BMI body mass index, CVD cardiovascular disease, eGFR estimated glomerular filtration rate, FPG fasting plasma glucose, HbA1c glycated hemoglobin, HDL high-density lipoprotein, IQR interquartile range, LDL low-density lipoprotein, UACR urinary albumin to creatinine ratio